On September 7, LENS rose 3.02% in regular trading, trading at 24.54 HKD/share, with turnover of approximately 83.16 million HKD. The rally was driven by a wave of bullish endorsements from major investment banks alongside accelerating new business developments.

Specifically, CLSA raised its target price to 30.7 HKD, Bank of America to 27 HKD, and Jefferies to 28 HKD, all maintaining buy-equivalent ratings. Meanwhile, UBS Group increased its H-share long position to 11.42%, up 0.76 percentage points, and JPMorgan raised its long position to 5.19%, up 0.65 percentage points. Analysts cited the company's Q2 turnaround — net profit of 726 million RMB with gross margin improving to 18.2% — as well as diversification into AI server structural components, UTG foldable screens, AI smart glasses, and embodied intelligence as key catalysts. Although H1 revenue declined 12.42% year-over-year to 28.87 billion RMB and net profit fell 49.52%, institutional optimism around new growth drivers and order ramp-ups in the second half provided repair momentum for the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)